Johnson & Johnson logo

Johnson & Johnson JNJ

$ 272.65 -2.21%
report update icon

Quarterly report 2026-Q3
added 10-21-2026

Country

usaUSA

IPO year

-

Industry

Biotechnology

Stock Exchange

NYSESPB

Shares

2.41 B

Market Cap[1]

$ 656 B

EBITDA (LTM)

$ 7.5 B

P/E (LTM)

23.160827

P/S (LTM)

6.588383

EPS (LTM)

11.13

Johnson & Johnson is a multinational corporation that specializes in healthcare products, medical devices, and pharmaceuticals. Founded in 1886, the company has grown to become one of the largest healthcare companies in the world, with operations in over 60 countries.

The company's products are used by millions of people every day, from baby shampoo and band-aids to prescription drugs and surgical equipment. Some of its most well-known brands include Tylenol, Neutrogena, and Listerine.

Johnson & Johnson is committed to improving the health and well-being of people around the world. The company invests heavily in research and development, with a focus on finding new treatments for diseases such as cancer, Alzheimer's, and HIV/AIDS.

In addition to its healthcare products, Johnson & Johnson is also known for its commitment to corporate social responsibility. The company has a long history of supporting various charitable causes, including disaster relief efforts and global health initiatives.

Overall, is a trusted and respected leader in the healthcare industry, with a strong track record of innovation and social responsibility.

Other stocks of industry "Biotechnology"

Issuer Price % 24h Market Cap Exchange Country
Reata Pharmaceuticals Reata Pharmaceuticals
RETA
- - $ 6.29 B Nasdaq Global Market,SPB usaUSA
Rhythm Pharmaceuticals Rhythm Pharmaceuticals
RYTM
$ 119.1 2.14 % $ 7.74 B Nasdaq Global Market,SPB usaUSA
iTeos Therapeutics iTeos Therapeutics
ITOS
- - $ 411 M Nasdaq Global Market usaUSA
Corbus Pharmaceuticals Holdings Corbus Pharmaceuticals Holdings
CRBP
$ 2.76 -8.35 % $ 36.8 M Nasdaq Global Market usaUSA
PolarityTE PolarityTE
PTE
- -0.82 % $ 1.78 M Nasdaq Capital Market usaUSA
Kronos Bio Kronos Bio
KRON
- 1.49 % $ 50.8 M Nasdaq Global Select Market usaUSA
Cullinan Management Cullinan Management
CGEM
$ 9.01 -2.86 % $ 543 M Nasdaq Global Select Market usaUSA
Sol-Gel Technologies Ltd. Sol-Gel Technologies Ltd.
SLGL
$ 54.13 2.46 % $ 151 M Nasdaq Global Select Market israelIsrael
Advaxis Advaxis
ADXS
- -9.65 % $ 45.9 M Nasdaq Capital Market usaUSA
Trevena Trevena
TRVN
- -46.58 % $ 31.8 M Nasdaq Capital Market usaUSA
Calithera Biosciences Calithera Biosciences
CALA
- -10.95 % $ 876 K Nasdaq Global Select Market usaUSA
Molecular Templates Molecular Templates
MTEM
- -23.43 % $ 495 K Nasdaq Capital Market usaUSA
Oncorus Oncorus
ONCR
- -8.54 % $ 3.19 M Nasdaq Global Market usaUSA
BioXcel Therapeutics BioXcel Therapeutics
BTAI
$ 0.07 9.81 % $ 855 K Nasdaq Global Select Market,SPB usaUSA
Novan Novan
NOVN
- -24.84 % $ 2.64 M Nasdaq Capital Market usaUSA
CohBar CohBar
CWBR
- -15.44 % $ 2.2 M Nasdaq Capital Market usaUSA
NeuBase Therapeutics NeuBase Therapeutics
NBSE
- -1.56 % $ 12.3 M Nasdaq Global Select Market usaUSA
Epizyme Epizyme
EPZM
- - $ 249 M Nasdaq Global Select Market usaUSA
Arena Pharmaceuticals Arena Pharmaceuticals
ARNA
- -6.81 % $ 3.04 B Nasdaq Global Select Market,SPB usaUSA
Scopus BioPharma Scopus BioPharma
SCPS
- -48.37 % $ 3.71 M Nasdaq Global Select Market usaUSA
Nabriva Therapeutics plc Nabriva Therapeutics plc
NBRV
- - $ 4.55 M Nasdaq Global Select Market irlandaIrlanda
Annovis Bio Annovis Bio
ANVS
$ 0.81 9.63 % $ 16.6 M NYSE American usaUSA
scPharmaceuticals scPharmaceuticals
SCPH
- - $ 218 M Nasdaq Global Select Market usaUSA
X4 Pharmaceuticals X4 Pharmaceuticals
XFOR
$ 3.02 -2.27 % $ 128 M Nasdaq Capital Market usaUSA
Entasis Therapeutics Holdings Entasis Therapeutics Holdings
ETTX
- - $ 105 M Nasdaq Global Market usaUSA
Citius Pharmaceuticals Citius Pharmaceuticals
CTXR
$ 0.52 -0.62 % $ 5.75 M Nasdaq Capital Market usaUSA
Athersys Athersys
ATHX
- 3.77 % $ 22.4 M Nasdaq Capital Market usaUSA
Global Blood Therapeutics Global Blood Therapeutics
GBT
- - $ 4.62 B Nasdaq Global Select Market,SPB usaUSA
Inozyme Pharma Inozyme Pharma
INZY
- - $ 207 M Nasdaq Global Select Market usaUSA
NanoString Technologies NanoString Technologies
NSTG
- -37.43 % $ 5.1 M Nasdaq Global Select Market usaUSA
Evogene Ltd. Evogene Ltd.
EVGN
$ 0.36 5.82 % $ 2.83 M Nasdaq Global Market israelIsrael
Humanigen Humanigen
HGEN
- -81.12 % $ 4.28 M Nasdaq Global Select Market usaUSA
CNS Pharmaceuticals CNS Pharmaceuticals
CNSP
$ 4.44 6.99 % $ 1.97 M Nasdaq Capital Market usaUSA
Sorrento Therapeutics Sorrento Therapeutics
SRNE
- -29.58 % $ 126 M Nasdaq Global Select Market usaUSA
Surface Oncology Surface Oncology
SURF
- - $ 59.7 M Nasdaq Global Select Market usaUSA
Sierra Oncology Sierra Oncology
SRRA
- -0.05 % $ 1.34 B Nasdaq Global Select Market canadaCanada
Gilead Sciences Gilead Sciences
GILD
$ 168.96 -0.77 % $ 210 B Nasdaq Global Select Market,SPB usaUSA
Vaccinex Vaccinex
VCNX
- -61.37 % $ 654 K Nasdaq Global Select Market usaUSA
Nymox Pharmaceutical Corporation Nymox Pharmaceutical Corporation
NYMX
- -19.68 % $ 18.4 M Nasdaq Capital Market canadaCanada
Jounce Therapeutics Jounce Therapeutics
JNCE
- - $ 98.4 M Nasdaq Global Select Market usaUSA
Cocrystal Pharma Cocrystal Pharma
COCP
$ 0.96 -4.95 % $ 10.8 M Nasdaq Capital Market usaUSA
Fortress Biotech Fortress Biotech
FBIO
$ 1.89 3.85 % $ 52.7 M Nasdaq Capital Market usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
- -24.86 % $ 820 K Nasdaq Global Select Market usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
- -11.43 % $ 502 K NYSE American usaUSA
Longeveron Longeveron
LGVN
$ 1.93 -8.53 % $ 33.9 B Nasdaq Global Select Market usaUSA
Mersana Therapeutics Mersana Therapeutics
MRSN
- - $ 3.56 B Nasdaq Global Select Market usaUSA
Akari Therapeutics, Plc Akari Therapeutics, Plc
AKTX
$ 6.51 14.22 % $ 438 B Nasdaq Capital Market britainBritain
CymaBay Therapeutics CymaBay Therapeutics
CBAY
- - $ 3.45 B Nasdaq Global Select Market usaUSA
Freeline Therapeutics Holdings plc Freeline Therapeutics Holdings plc
FRLN
- - $ 384 M Nasdaq Global Select Market britainBritain
Allakos Allakos
ALLK
- - $ 28.6 M Nasdaq Global Select Market,SPB usaUSA

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.